Predicitive biomarker for cancer treatment with ADCC enhanced antibodies
摘要
The present invention is directed to methods for identifying which patients diagnosed with cancer will most benefit from treatment with an anti-cancer therapy comprising an ADCC-enhanced antibody.
申请公布号
AU2012371260(A1)
申请公布日期
2014.07.10
申请号
AU20120371260
申请日期
2012.03.02
申请人
ROCHE GLYCART AG
发明人
GERDES, CHRISTIAN;GIMMI, CLAUDE;HOLLINGSWORTH, SIMON;MANENTI, LUIGI;RUEGER, RUEDIGER;UMANA, PABLO
